Kimberly-Clark Acquires Kenvue in $49 Billion Deal
Consumer giant Kimberly-Clark, maker of Huggies diapers and Kleenex tissues, is buying Kenvue, the company behind Tylenol and Band-Aids, in a $49 billion merger.
The deal comes amidst controversy, as the Trump administration recently linked acetaminophen, the active ingredient in Tylenol, to autism, despite a lack of clear scientific evidence. Kenvue has denounced these claims as "simply false."
Kenvue has called the assertions linking acetaminophen to autism "simply false."
- Tylenol
- Band-Aids
- Listerine
- Neutrogena
- Aveeno
According to Kimberly-Clark CEO Mike Hsu, the merger will create "a global health and wellness leader" by combining the two "iconic companies".
Author's summary: Kimberly-Clark buys Kenvue for $49 billion.
More News
- BOK Center debuts 100% plant-based concession menu for Billie Eilish shows
- Unwrap The Wildlife Trusts’ winter challenge and let nature bring you joy! | The Wildlife Trusts
- The legitimacy trap: How international institutions sustain the Houthis' hold on Yemen
- Climatic Hanover Tops Day One Of Standardbred Horse Sale